《中国临床肿瘤学会(CSCO)原发性肺癌诊疗指南 2016.V1》正式发布!

2016-11-23 中国临床肿瘤学会指南工作委员会 CSCO会议 微信号

2016年11月23日,中国临床肿瘤学会(CSCO)正式在网站发布《中国临床肿瘤学会 (CSCO) 原发性肺癌诊疗指南 2016.V1》(以下简称《指南》)。 CSCO理事长吴一龙教授在今年4月份《指南》发布会上称:“CSCO恶性肿瘤临床诊治指南的特色,首先是兼顾地区发展不平衡;第二是基于资源和药物的可及性;第三是关注肿瘤治疗的价值。” 肺癌是我国及世界范围内发病率最高的恶性肿

2016年11月23日,中国临床肿瘤学会(CSCO)正式在网站发布《中国临床肿瘤学会 (CSCO) 原发性肺癌诊疗指南 2016.V1》(以下简称《指南》)。
 
CSCO理事长吴一龙教授在今年4月份《指南》发布会上称:“CSCO恶性肿瘤临床诊治指南的特色,首先是兼顾地区发展不平衡;第二是基于资源和药物的可及性;第三是关注肿瘤治疗的价值。”
 
肺癌是我国及世界范围内发病率最高的恶性肿瘤,作为严重影响人类健康的疾病,在循证医学证据基础上进行规范治疗非常重要。以往,中国的肺癌诊治现状主要是借鉴国外的指南,但我国不同地区之间的诊治差异性很大,疾病各有特点。为能更好地规范和指导我国的肺癌诊断和治疗,CSCO组织肺癌诊治领域专家,撰写具有中国特色的肺癌诊治指南。
 
专家队伍

(按《指南》内科、外科、放疗及病理内容顺序)上海交通大学附属胸科医院陆舜教授,同济大学上海市肺科医院周彩存教授,吉林省肿瘤医院程颖教授,中国医学科学院肿瘤医院王洁教授,福建省肿瘤医院黄诚教授,广东省肺癌研究所、广东省人民医院、广东省医学科学院吴一龙教授、周清教授、钟文昭教授,天津医科大学肿瘤医院王长利教授,中国医学科学院肿瘤医院王绿化教授,四川大学华西医院卢铀教授,武汉大学人民医院宋启斌教授,及北京大学肿瘤医院林冬梅教授等13位教授,参考国外指南和最新研究结果并结合多年临床经验,编写了这部《指南》。

“我们借助CSCO平台,建立了包括《指南》在内的七大瘤种的指南。以肺癌为例,中国的肺癌诊治与国外相比,有自己的独特性。基于此,《指南》从我国国情出发,具有很好的可行性。”《指南》执笔人之一、广东省肺癌研究所、广东省人民医院、广东省医学科学院周清教授介绍道。
 
《指南》重要特点

该《指南》在制定过程中,其内容及格式上,均考虑了我国国情及指南可行性的问题。

首先,于执行层面上,分为基本策略与可选策略。基本策略面向县级以上医院,是最基本的要求,必须考虑高证据级别和可及性。可选策略是高级选择对不同地区不同级别医疗单位的补充选择。其次,《指南》撰写具有创新格式,以表格和文字描述相结合的方式体现内容。同时,为扩充知识内容,《指南》涵盖了参考文献和证据级别,可通过参考文献进行深层次的阅读。”

《指南》为我国首部依托CSCO发布的、内容详尽、切实可行的肺癌诊疗指南,能有效地规范我国肺癌诊断和治疗,通过对指南的推广和使用,有望推动中国肺癌诊断和治疗的发展,提高我国肺癌诊疗水平,延长肺癌患者生存时间并提高肺癌患者生活质量,为我国的抗肿瘤事业贡献力量。




版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1846520, encodeId=9df518465204f, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Wed Feb 08 04:43:00 CST 2017, time=2017-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390750, encodeId=32c01390e506e, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82896, encryptionId=8eeb828963a, topicName=肿瘤学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Fri Nov 25 06:43:00 CST 2016, time=2016-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552967, encodeId=92a9155296e13, content=<a href='/topic/show?id=eb943e0942f' target=_blank style='color:#2F92EE;'>#原发性肺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37094, encryptionId=eb943e0942f, topicName=原发性肺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f2614322437, createdName=bioon8, createdTime=Fri Nov 25 06:43:00 CST 2016, time=2016-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157761, encodeId=9e4615e76119, content=全文那。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Thu Nov 24 01:34:33 CST 2016, time=2016-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157742, encodeId=a47215e74281, content=口号响亮是好的,但要真正战胜还很远, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Wed Nov 23 23:57:49 CST 2016, time=2016-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157707, encodeId=177e15e70778, content=很好的指南, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161123/IMG58359820CFBE13968.jpg, createdBy=41741984637, createdName=阿光仔, createdTime=Wed Nov 23 21:19:53 CST 2016, time=2016-11-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1846520, encodeId=9df518465204f, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Wed Feb 08 04:43:00 CST 2017, time=2017-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390750, encodeId=32c01390e506e, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82896, encryptionId=8eeb828963a, topicName=肿瘤学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Fri Nov 25 06:43:00 CST 2016, time=2016-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552967, encodeId=92a9155296e13, content=<a href='/topic/show?id=eb943e0942f' target=_blank style='color:#2F92EE;'>#原发性肺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37094, encryptionId=eb943e0942f, topicName=原发性肺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f2614322437, createdName=bioon8, createdTime=Fri Nov 25 06:43:00 CST 2016, time=2016-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157761, encodeId=9e4615e76119, content=全文那。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Thu Nov 24 01:34:33 CST 2016, time=2016-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157742, encodeId=a47215e74281, content=口号响亮是好的,但要真正战胜还很远, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Wed Nov 23 23:57:49 CST 2016, time=2016-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157707, encodeId=177e15e70778, content=很好的指南, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161123/IMG58359820CFBE13968.jpg, createdBy=41741984637, createdName=阿光仔, createdTime=Wed Nov 23 21:19:53 CST 2016, time=2016-11-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1846520, encodeId=9df518465204f, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Wed Feb 08 04:43:00 CST 2017, time=2017-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390750, encodeId=32c01390e506e, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82896, encryptionId=8eeb828963a, topicName=肿瘤学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Fri Nov 25 06:43:00 CST 2016, time=2016-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552967, encodeId=92a9155296e13, content=<a href='/topic/show?id=eb943e0942f' target=_blank style='color:#2F92EE;'>#原发性肺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37094, encryptionId=eb943e0942f, topicName=原发性肺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f2614322437, createdName=bioon8, createdTime=Fri Nov 25 06:43:00 CST 2016, time=2016-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157761, encodeId=9e4615e76119, content=全文那。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Thu Nov 24 01:34:33 CST 2016, time=2016-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157742, encodeId=a47215e74281, content=口号响亮是好的,但要真正战胜还很远, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Wed Nov 23 23:57:49 CST 2016, time=2016-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157707, encodeId=177e15e70778, content=很好的指南, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161123/IMG58359820CFBE13968.jpg, createdBy=41741984637, createdName=阿光仔, createdTime=Wed Nov 23 21:19:53 CST 2016, time=2016-11-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1846520, encodeId=9df518465204f, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Wed Feb 08 04:43:00 CST 2017, time=2017-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390750, encodeId=32c01390e506e, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82896, encryptionId=8eeb828963a, topicName=肿瘤学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Fri Nov 25 06:43:00 CST 2016, time=2016-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552967, encodeId=92a9155296e13, content=<a href='/topic/show?id=eb943e0942f' target=_blank style='color:#2F92EE;'>#原发性肺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37094, encryptionId=eb943e0942f, topicName=原发性肺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f2614322437, createdName=bioon8, createdTime=Fri Nov 25 06:43:00 CST 2016, time=2016-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157761, encodeId=9e4615e76119, content=全文那。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Thu Nov 24 01:34:33 CST 2016, time=2016-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157742, encodeId=a47215e74281, content=口号响亮是好的,但要真正战胜还很远, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Wed Nov 23 23:57:49 CST 2016, time=2016-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157707, encodeId=177e15e70778, content=很好的指南, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161123/IMG58359820CFBE13968.jpg, createdBy=41741984637, createdName=阿光仔, createdTime=Wed Nov 23 21:19:53 CST 2016, time=2016-11-23, status=1, ipAttribution=)]
    2016-11-24 jihuaijun1112

    全文那。。。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1846520, encodeId=9df518465204f, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Wed Feb 08 04:43:00 CST 2017, time=2017-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390750, encodeId=32c01390e506e, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82896, encryptionId=8eeb828963a, topicName=肿瘤学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Fri Nov 25 06:43:00 CST 2016, time=2016-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552967, encodeId=92a9155296e13, content=<a href='/topic/show?id=eb943e0942f' target=_blank style='color:#2F92EE;'>#原发性肺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37094, encryptionId=eb943e0942f, topicName=原发性肺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f2614322437, createdName=bioon8, createdTime=Fri Nov 25 06:43:00 CST 2016, time=2016-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157761, encodeId=9e4615e76119, content=全文那。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Thu Nov 24 01:34:33 CST 2016, time=2016-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157742, encodeId=a47215e74281, content=口号响亮是好的,但要真正战胜还很远, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Wed Nov 23 23:57:49 CST 2016, time=2016-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157707, encodeId=177e15e70778, content=很好的指南, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161123/IMG58359820CFBE13968.jpg, createdBy=41741984637, createdName=阿光仔, createdTime=Wed Nov 23 21:19:53 CST 2016, time=2016-11-23, status=1, ipAttribution=)]
    2016-11-23 cqykthl

    口号响亮是好的,但要真正战胜还很远

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1846520, encodeId=9df518465204f, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Wed Feb 08 04:43:00 CST 2017, time=2017-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390750, encodeId=32c01390e506e, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82896, encryptionId=8eeb828963a, topicName=肿瘤学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Fri Nov 25 06:43:00 CST 2016, time=2016-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552967, encodeId=92a9155296e13, content=<a href='/topic/show?id=eb943e0942f' target=_blank style='color:#2F92EE;'>#原发性肺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37094, encryptionId=eb943e0942f, topicName=原发性肺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f2614322437, createdName=bioon8, createdTime=Fri Nov 25 06:43:00 CST 2016, time=2016-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157761, encodeId=9e4615e76119, content=全文那。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Thu Nov 24 01:34:33 CST 2016, time=2016-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157742, encodeId=a47215e74281, content=口号响亮是好的,但要真正战胜还很远, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Wed Nov 23 23:57:49 CST 2016, time=2016-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157707, encodeId=177e15e70778, content=很好的指南, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161123/IMG58359820CFBE13968.jpg, createdBy=41741984637, createdName=阿光仔, createdTime=Wed Nov 23 21:19:53 CST 2016, time=2016-11-23, status=1, ipAttribution=)]
    2016-11-23 阿光仔

    很好的指南

    0

相关资讯

BJC:步行能改善肺癌患者的睡眠

睡眠障碍和不良的休息-活动节奏会降低生活质量,而这些在肺癌患者里是十分常见的。 本试验研究了为期12周的运动干预,包括以家庭为基础的步行运动训练和每周运动,对111例肺癌患者的影响。参与者被随机分配接受干预或常规护理。 结果包括客观睡眠(总睡眠时间 TST;睡眠效率 SE;睡眠潜伏期 SOL;入睡后醒来 WASO)、主观睡眠(匹兹堡睡眠质量指数,PSQI)、休息-活动节奏(r24和I&

“家庭癌”越来越多,难道癌症真的会传染?早看早预防!

或许你会发现这样的现象,在某些家庭中有一人患癌症,其他家庭成员可能同样患有这样的癌症,医学上将其称作为“家庭癌”。但“家庭癌”到底是怎么一回事呢?癌症真的会传染吗?回答其实是否定的。癌症本身并不直接具有传染性,但有4种导致癌前病变的病毒和细菌有一定的传染性:乙型\丙型肝炎病毒、幽门螺旋杆菌、人乳头瘤病毒(HPV)。而这些病毒会通过家庭成员的生活方式、饮食习惯和环境等因素互相影响。有关肿瘤流行病学研

新发恶性肿瘤 1/5是肺癌

本月是第16个“全球肺癌关注月”。昨日,北京晨报记者从市卫计委获悉,根据最新统计,每年5个新发恶性肿瘤中就有1个是肺癌,肺癌占据本市男性新发恶性肿瘤的第1位、女性的第2位,防控形势不容乐观。

Nature:中国进行全球CRISPR技术人体应用,治疗肺癌

今年7月,《自然》杂志曾报道成都的四川大学华西医院有望率先将CRISPR基因编辑技术应用到人体。今日,《自然》杂志进行了后续报道,并确认全球首个CRISPR技术的人体应用已在中国启动。CRISPR基因编辑技术是近年生物技术领域的热点。在科研领域,它已展现了巨大的潜力,并帮助科学家们建立了一个个不同的疾病模型,让我们了解特定基因的重要性。自然而然,科研人员下一步关注的,就是能否将这一革命性的技术应用

Nat Med:血液中的循环肿瘤细胞可以预测肺癌治疗效果

肺癌是全世界发病率和死亡率最高的癌症之一。肺癌主要分为小细胞肺癌和非小细胞肺癌两大类。不同类型的肺癌,治疗策略和预后情况也不尽相同。Nature Medicine发表的一项新研究表明,血检可以预测小细胞肺癌(SCLC)患者对治疗的应答情况。在癌症的发展过程中,肿瘤细胞会离开实体瘤进入血液循环,成为循环肿瘤细胞(CTC)。曼彻斯特大学的研究人员从31名小细胞肺癌患者的血液中分离循环肿瘤细胞进行研究。

Science:1天1包烟有多可怕?每年150个突变!

近日,科学家们研究了吸烟对身体不同器官所造成的灾难性的基因损伤,鉴定出了吸烟导致突变背后多种不同的机制。来自英国Wellcome Trust Sanger研究所、美国Los Alamos国家实验室等机构的科学家们发现,每天吸一包烟的“吸烟者”每年每个肺细胞(lung cell)中会累积平均150个额外突变。11月4日,发表在Science杂志山的这一项研究(论文题目:Mutational si